Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Language
Publication year range
1.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-1029918

ABSTRACT

Objective:This study aims to explore the prevalence of hepatitis E virus (HEV) infection in patients and the screening value of serological indicators for HEV infection patients.Methods:Retrospective analysis was conducted on 97 440 cases of anti-HEV IgM and IgG simultaneously tested in two Beijing hospitals from January 1, 2018 to August 31, 2023. Among them, there were 61 005 males and 36 435 females, with an average age of 51.65±13.05 years old. According to the positivity of anti HEV specific antibodies, they were divided into anti-HEV IgM positive group (3 588 cases), anti-HEV IgG positive group (18 083 cases), and anti-HEV antibody negative group (78 892 cases). Results of HEV RNA, liver function, AFP, PIVKA-Ⅱ and PT were collected, and their basic clinical information were recorded. The prevalence of HEV infection in patients, as well as the relationship between the positivity of anti-HEV specific antibodies and the patient′s age group, HEV RNA, and clinical characteristics were analyzed.Results:Among 97 440 patients who tested anti-HEV IgM and IgG simultaneously, the positivity rate of anti-HEV IgM was 3.68% (3 588/97 440), and was 18.56% for anti-HEV IgG (18 083/97 440). The overall positivity rates of anti-HEV IgM in two Beijing hospitals from 2018 to 2023 were 2.51%, 2.53%, 3.02%, 4.59%, 5.72%, and 4.26% ( χ2=1 401.73, P<0.001), while the positivity rates of anti-HEV IgG were 12.56%, 12.32%, 12.85%, 22.65%, 27.42%, and 26.66% ( χ2=1 058.29, P<0.001). These rates showed a gradual increase until 2023 when a decline was observed. The positivity rates of anti-HEV IgM (2.28%, 3.60%, 4.47%) ( χ2=89.62, P<0.001) and IgG (4.71%, 17.86%, 25.94%) ( χ2=2 017.32, P<0.001) increased with age in patients who aged 1-30, >30-60, and over 60 years old. The age and ALB values of patients in the anti-HEV IgM positive group were lower than the IgG-positive group, while the proportion of males, TBIL, ALT, AFP and PT values were higher than the IgG-positive group, and the differences were statistically significance ( P<0.05). Furthermore, patients in both the anti-HEV IgM and IgG positive groups had higher age, male proportion, TBIL, ALT, AFP, PIVKA-Ⅱ, and PT values than the anti-HEV negative group. Additionally, both groups had lower ALB values than the anti-HEV negative group, all of which were statistically significant ( P<0.05). 2 162 HEV infected patients were grouped based on HEV RNA positivity. The proportion of anti-HEV IgM single positive, IgG single positive, IgM+IgG double positive, and antibody negative patients in the HEV RNA positive group were 5.42% (18/332), 3.62% (12/332), 90.36% (300/332), and 0.60% (2/332), respectively. Among them, the proportion of anti-HEV IgM+IgG double positive patients in the HEV RNA positive group was higher than that in the HEV RNA negative group ( χ2=302.87, P<0.001), while the proportion of anti-HEV IgG single positive ( χ2=174.36, P<0.001) and anti-HEV antibody negative patients ( χ2=59.28, P<0.001) were lower than that in the HEV RNA negative group, both of which were statistically significant ( P<0.001). In addition, the positive rates of HEV RNA in anti-HEV IgM positive, IgG positive, and antibody negative patients were 29.23% (318/1 088), 17.59% (312/1 774), and 0.65% (2/306), respectively. Conclusion:The HEV infection rate among patients declined in 2023. HEV infection is age-related, with older individuals being more susceptible. Abnormal liver function and jaundice were commonly observed during HEV infection. It is crucial to note that the absence of anti-HEV specific antibodies cannot rule out HEV infection; therefore, additional testing for HEV RNA and/or HEV Ag is necessary for accurate diagnosis.

2.
Basic & Clinical Medicine ; (12): 1784-1791, 2023.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-1018541

ABSTRACT

Objective To explore the role of G protein pathway suppressor 2(GPS2)in regulating proliferation,migration and invasion in hepatocellular carcinoma cell line MHCC-97H.Methods The expression of GPS2 in hepatocellular carcinoma(HCC)cells were detected using quantitative PCR or Western blot;GPS2 was either over-expressed or knocked down in HCC cells using over-expression vectors or short hairpin RNAs(shRNAs)for GPS2,respectively.Clone formation assay,scratch assay and Transwell assay were used to detect the effects of GPS2 on proliferation,migration and invasion of HCC cells.Results In HCC cells,over-expression of GPS2 was found to inhibit the proliferation,migration and invasion of HCC cells MHCC-97H,while knockdown of GPS2 up-regulated proliferation,migration and invasion of MHCC-97H(P<0.05).The over-expression of GPS2 in MHCC-97H cells was found to inhibit the expression of cell proliferation,migration and invasion-related factors such as EGFR,MMP1,MMP3 and MMP9,while knockdown of GPS2 upregulated the expression of these factors(P<0.05).Conclusions GPS2 is a novel HCC regulatory factor that inhibits proliferation,migration and invasion of HCC cells.

3.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-958638

ABSTRACT

Objective:To establish a model C-GALAD for detecting hepatocellular carcinoma (HCC) from the chronic liver disease and healthy people based on the serum markers.Methods:A clinical cohort including 229 hepatocellular carcinoma patients, 2 317 patients with chronic liver disease and 982 healthy people, was retrospectively collected from eight hospitals or physical examination institutions from April 2018 to October 2020. The data were divided into a training set and a testing set by stratified sampling with a 6∶4 ratio. A predictive model was established on the training set using a logistic backward regression method and validated on the testing set. In addition, clinical data from March to July 2021 in Beijing You′ an Hospital affiliated to Capital Medical University, including 84 patients with liver cancer and 204 patients with chronic liver disease collected were used for external independent validation of the model. The receiver operating characteristic curve (ROC) area under curve (AUC), the sensitivity and the specificity were used to evaluate the effectiveness of the model.Results:Through the logistic backward regression method, the seven signatures including age, gender, alpha-fetoprotein (AFP), alpha-fetoprotein alloplasm-3 ratio (AFP-L3%), des-gamma-carboxyprothrombin(DCP), platelet (PLT) and total bilirubin (TBIL) were selected as risk factors in the detection model. The area under the ROC curve (AUC) of the model on the testing set was 0.954, with an 88.04% sensitivity and a 94.85% specificity, and the AUC of model on the external independent validation set was 0.943, with an 89.29% sensitivity and a 90.2% specificity, which were better than other published models.Conclusion:The C-GALAD Ⅱ model can accurately predict the risk of hepatocellular carcinoma occurrence, and thus provide a trustworthy diagnosis method of hepatocellular carcinoma.

4.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-877100

ABSTRACT

Objective To investigate the epidemiological characteristics of metabolic syndrome in the elderly, and to develop scientific prevention and control measures. Methods Physical examination personnel in Xianyang district from January 2017 to January 2020 were selected by random sampling method. The prevalence and epidemiological characteristics of the patients with metabolic syndrome were calculated according to the diagnostic criteria of metabolic syndrome. Intervention measures were implemented for patients with metabolic syndrome, and changes in survival and body quality were compared before and after intervention. SPSS 20.0 software was used for T test, rank sum test and Spearman rank correlation analysis, and the test level was α=0.05. Results There were 587 cases of metabolic syndrome in Xianyang area, and the overall prevalence rate was 13.81%. Complete clinical data of 566 elderly patients with metabolic syndrome were obtained. Age of 60~69 years old, overweight, obesity, activity time 1). After the intervention, scores of diet management, exercise management and cognition management in all age groups were higher than those before the intervention (P<0.05). In addition, values of triglyceride, high-density lipoprotein and BMI were better than those before the intervention (P<0.05). Conclusion Age of 60~69 years old, overweight, obesity, activity time <3 hours per day, sitting time ≥8 hours per day, smoking and alcohol consumption are the risk factors for the occurrence of metabolic syndrome in the elderly. Targeted interventions are of vital importance in helping patients to establish suitable self-management and executive ability.

5.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-871926

ABSTRACT

Autoimmune disease is a kind of immune dysfunction disease caused by gene and environmental factors. At present, there are some difficulties in early diagnosis, prognosis evaluation and curative effect evaluation. More and more autoantibodies have been found and confirmed to be closely related to the occurrence and development of autoimmune diseases with the deepening of related research. Accurate autoantibody detection is helpful to improve the diagnostic efficiency, therapeutic effect and quality of life of patients with autoimmune diseases.

6.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-545880

ABSTRACT

Among the theories supporting the increase of incidence of allergy during the last several decades is the concept that environmental pollutants may play a vital role. The present review reported the effect of different types of pollutants on the development, modulation and persistence of allergic reactions. It analyzed how pollutants including ozone, nitrogen dioxide and particulate materials contribute to allergy directly and indirectly. It reviewed several possible mechanisms involved in the enhancement of allergic inflammation by air pollutants. Finally, it made a delineation of many factors affecting allergy, which could provide useful information on the prevention of allergy.

SELECTION OF CITATIONS
SEARCH DETAIL